Earnings Feed
Start Free
Cullinan Therapeutics, Inc.·4

May 23, 4:11 PM ET

Ebeling Thomas 4

4 · Cullinan Therapeutics, Inc. · Filed May 23, 2024

Insider Transaction Report

Form 4
Period: 2024-05-23
Cullinan Therapeutics, Inc.CGEM
Ebeling Thomas
Director
Transactions
  • Award

    Common Stock

    2024-05-23$12.73/sh+16,475$209,727→ 168,203 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-23−16,475→ 0 total
    Exercise: $12.73From: 2023-06-08Exp: 2032-06-21→ Common Stock (16,475 underlying)
  • Award

    Common Stock

    2024-05-23$4.30/sh+84,224$362,163→ 151,728 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-23−84,224→ 0 total
    Exercise: $4.30Exp: 2030-10-28→ Common Stock (84,224 underlying)
Footnotes (1)
  • [F1]25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4